• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LAI Zengwei, XU Li, SONG Zhuang, LEI Xiantao, XU Qinglong, SUN Hongbin. Asymmetric synthesis of an amine-azaspiro as the key intermediate of sitafloxacin[J]. Journal of China Pharmaceutical University, 2014, 45(4): 400-404. DOI: 10.11665/j.issn.1000-5048.20140403
Citation: LAI Zengwei, XU Li, SONG Zhuang, LEI Xiantao, XU Qinglong, SUN Hongbin. Asymmetric synthesis of an amine-azaspiro as the key intermediate of sitafloxacin[J]. Journal of China Pharmaceutical University, 2014, 45(4): 400-404. DOI: 10.11665/j.issn.1000-5048.20140403

Asymmetric synthesis of an amine-azaspiro as the key intermediate of sitafloxacin

More Information
  • As an important intermediate of quinolone antibacterial agents such as sitafloxacin and olamufloxacin, 7-(S)-tert-butoxycarbonylamino-5-azaspiro[2. 4]heptane has received much attention. Previous syntheses suffered from low yielding and poor stereoselectivity. In this study, an asymmetric synthetic approach was developed to optically pure amine-azaspiro compound with convenient manipulation, excellent yields and high stereoselectivity.
  • [1]
    Kimura K,Atarashi S,Kawakami K,et al.(Fluorocyclopropyl)quinolones.2 Synthesis and stereochemical structure-activity relationships of chiral 7-(7-amino-5-azaspiro[2.4] heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents[J].J Med Chem,1994,37(20):3 344-3 352.
    [2]
    Liu M,Liu XR.The antimicrobial drug sitafloxacin hydrate[J].Shanghai Pharm(上海医药),2010,31(3):122-124.
    [3]
    Chen GB,Yue LJ.Research progress on the synthesis of sitafloxacin[J].Chin J Syn Chem(合成化学),2012,20:7-12.
    [4]
    Chen LW,Zhang HB,Liang HX,et al.Synthesis of sitafloxacin[J].Chin J Pharm(中国医药工业杂志).2014,45(1):1-4.
    [5]
    Hayakawa I,Atarashi S,Imamura M,et al. Preparation of 7-(azaspiroalkanyl)quinolonecarboxylates and analogs as bactericides:CN,1040790[P].1990-03-28.
    [6]
    Akiba T,Ebata T,Saito T,et al.Processes for preparing cyclic compounds:CN,1191529[P].1998-08-26.
    [7]
    Nakayama K,Muto M,Saito T,et al.Processes for preparation of bicyclic compounds(aminoazaspiroalkanes)and intermediates therefor:CN,1293054[P].2007-01-03.
    [8]
    Nakayama K,Muto M,Saito T,et al.Processes for preparation of bicyclic compounds(aminoazaspiroalkanes)and intermediates therefor:CN,100473645[P].2009-04-01.
    [9]
    Satoh K,Imura A,Miyadera A,et al.An Efficient synthesis of key intermediate of Du-6859a via asymmetric microbial reduction[J].Chem Pharm Bull,1998,46(4):587-590.
    [10]
    Daniel JP,Steven AK,Frederick AP,et al.Enantioselective synthesis of 3-aminopyrrolidines:US,6197974B1[P].2001-03-06.
    [11]
    Yao Y,Fan W,Li W,et al.Synthesis of(S)-7-amino-5-azaspiro[2.4] heptane via highly enantioselective hydrogenation of protected ethyl 1-(2-aminoaceto)cyclopropanecarboxylates[J].J Org Chem,2011,76(8):2 807-2 813.
    [12]
    Chakraborty TK,Azhar Hussain K,Venkat Reddy G.α-Phenylglycinol as chiral auxiliary in diastereoselective strecker synthesis of α-amino acids[J].Tetrahedron,1995,51(33):9 179-9 190.
    [13]
    Sun H,Xu L.Preparation of optically active cyclic compound: CN,103012198[P].2013-04-03.
  • Related Articles

    [1]CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002
    [2]JIANG Xiaomei, LIU Chong. Neuroprotective effect of glycyrrhizin on diabetic retinopathy[J]. Journal of China Pharmaceutical University, 2020, 51(6): 711-717. DOI: 10.11665/j.issn.1000-5048.20200610
    [3]MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316
    [4]TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315
    [5]YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105
    [6]TANG Qian, CHEN Song, GAO Xiangdong. Advances of mechanisms of metabolic memory-based diabetic complications and therapeutic drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 622-628. DOI: 10.11665/j.issn.1000-5048.20170519
    [7]HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
    [8]WANG Xin-ting, ZHANG Mian, GUO Hai-fang, LIU Can, HU Nan, LIU Li, LIU Xiao-dong. Effect and mechanism of atorvastatin on blood glucose of mild diabetic rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 453-459.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]PREVENTION AND TREATMENT OF ALLOXAN-INDUCED DIABETES IN MICE BY POLYSACCHARIDES FROM SPORE OF TREMELLA FUCIFORMIS BERK[J]. Journal of China Pharmaceutical University, 1988, (4): 303-304.
  • Cited by

    Periodical cited type(2)

    1. 林会平,孙国绍,梁波. 两种7-羟基香豆素衍生物的合成和NMR分析. 广州化学. 2020(01): 31-37 .
    2. 雷志伟,尹荣秀,李露露,郭灿. 香豆素类化合物合成的研究概况. 贵州茶叶. 2019(03): 18-21 .

    Other cited types(2)

Catalog

    Article views (1086) PDF downloads (1867) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return